After Hours Summary: ORCL -6.4%, TKR +5% following earnings/guidance, ARNA +23% on positive ulcerative colitis trial resultsAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: TKR +5.1%, HQY +1%
Companies trading higher in after hours in reaction to news: ARNA +23% (reports positive phase 2 results from the OASIS trial for etrasimod in patients with ulcerative colitis), FNJN +10% (Halcyon Long Duration Recovery discloses 14.2% active stake; received the $65 mln payment due from Symantec), ELGX +7.9% (announces the first results from ENCORE, a pooled, global analysis of several prospective clinical trials and registries studying polymer endovascular aneurysm repair (Polymer EVAR) using Ovation Abdominal Stent Graft Systems), MRNS +7.6% (initiated with Buy and $13 tgt at Mizuho), AMTX +6% (continuation of last week's move higher), BB +5% (BlackBerry and Microsoft partner to offer enterprises a solution that integrates BlackBerry's mobility/security with Microsoft's cloud/productivity products), APHB +3.2% (indicated slightly higher after announcing collaboration with the Western Sydney and the Westmead Institute for Medical Research based in Sydney, Australia), GOGO +1.2% (ticking higher; Senator Investment Group (Alexander Klabin) discloses increased/active stake), ZS +1.1% (ongoing volatility - recent IPO)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: AVGR -17.3%, GPI -9.6% (light volume; says Q1 earnings will be negatively affected by weak market conditions), ORCL -6.4%
Companies trading lower in after hours in reaction to news: NOG -12.2% (sees Q1 production up 5-6%; raises FY18 production growth to +18-22%; commences underwritten public offering of an aggregate value of $105 mln of shares of its common stock), PTI -7.9% (proposes public offering of 9 mln shares of common stock ), GLYC -5.5% (to offer 4.5 mln shares of common stock in underwritten public offering), OPNT -4.6% (pulling back after today's 28% move higher in midday trade -- has filed amendment to prospectus dated November 7, 2017 to update the amount of shares eligible to sell to 20 mln; announced that Pres/CEO Roger Crystal will provide corporate overview at the Oppenheimer Annual Healthcare Conference, on March 21 at 1pm ET), FB -1% (edging lower in after hours on report that its chief security officer is now leaving)
